非酒精性脂肪性肝炎（NASH）：针对NASH中凋亡信号调节激酶1（ASK1）的新型治疗策略。 - Suppr

NASH: Novel therapeutic strategies targeting ASK1 in NASH.

作者信息

Schuster Susanne, Feldstein Ariel E

机构信息

Department of Pediatrics, University of California, San Diego, Biomedical Research Building II, 9500 Gilman Drive, MC0602, La Jolla, California 92093, USA.

出版信息

Nat Rev Gastroenterol Hepatol. 2017 Jun;14(6):329-330. doi: 10.1038/nrgastro.2017.42. Epub 2017 Apr 5.

DOI:10.1038/nrgastro.2017.42

PMID:28377639

Abstract

摘要

相似文献

NASH: Novel therapeutic strategies targeting ASK1 in NASH.

Nat Rev Gastroenterol Hepatol. 2017 Jun;14(6):329-330. doi: 10.1038/nrgastro.2017.42. Epub 2017 Apr 5.

The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis.

Nat Med. 2018 Jan;24(1):84-94. doi: 10.1038/nm.4453. Epub 2017 Dec 11.

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates.

Nat Med. 2017 Apr;23(4):439-449. doi: 10.1038/nm.4290. Epub 2017 Feb 20.

Impact of neutralizing antibodies against AAV is a key consideration in gene transfer to nonhuman primates.

Nat Med. 2018 Jun;24(6):699. doi: 10.1038/s41591-018-0062-2.

Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitis.

Arab J Gastroenterol. 2014 Mar;15(1):6-11. doi: 10.1016/j.ajg.2014.01.009. Epub 2014 Feb 7.

CD44 is a key player in non-alcoholic steatohepatitis.

J Hepatol. 2017 Aug;67(2):328-338. doi: 10.1016/j.jhep.2017.03.003. Epub 2017 Mar 16.

An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease.

BMC Med. 2018 Sep 12;16(1):170. doi: 10.1186/s12916-018-1136-1.

Non-Alcoholic Fatty Liver Disease.

Adv Exp Med Biol. 2017;960:443-467. doi: 10.1007/978-3-319-48382-5_19.

The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.

Nutrients. 2017 Feb 27;9(3):198. doi: 10.3390/nu9030198.

Circulating Soluble Fas and Fas Ligand Levels Are Elevated in Children with Nonalcoholic Steatohepatitis.

Dig Dis Sci. 2015 Aug;60(8):2353-9. doi: 10.1007/s10620-015-3614-z. Epub 2015 Mar 13.

引用本文的文献

Rational design and discovery of potent PROTAC degraders of ASK1: a targeted therapy in MASH.

RSC Med Chem. 2025 Jun 6. doi: 10.1039/d5md00252d.

The role of ubiquitination and deubiquitination in the pathogenesis of non-alcoholic fatty liver disease.

Front Immunol. 2025 Apr 11;16:1535362. doi: 10.3389/fimmu.2025.1535362. eCollection 2025.

The emerging role of E3 ubiquitin ligases and deubiquitinases in metabolic dysfunction-associated steatotic liver disease.

J Transl Med. 2025 Mar 25;23(1):368. doi: 10.1186/s12967-025-06255-2.

Caffeine ameliorates metabolic-associated steatohepatitis by rescuing hepatic Dusp9.

Redox Biol. 2025 Mar;80:103499. doi: 10.1016/j.redox.2025.103499. Epub 2025 Jan 22.

Potential therapeutic strategies for MASH: from preclinical to clinical development.

Life Metab. 2024 Jul 6;3(5):loae029. doi: 10.1093/lifemeta/loae029. eCollection 2024 Oct.

Synthesis and biological evaluation of quinoxaline derivatives as ASK1 inhibitors.

J Enzyme Inhib Med Chem. 2024 Dec;39(1):2414382. doi: 10.1080/14756366.2024.2414382. Epub 2024 Oct 21.

Active role of the immune system in metabolic dysfunction-associated steatotic liver disease.

Gastroenterol Rep (Oxf). 2024 Oct 15;12:goae089. doi: 10.1093/gastro/goae089. eCollection 2024.

Hyperphosphorylation of hepatic proteome characterizes nonalcoholic fatty liver disease in S-adenosylmethionine deficiency.

iScience. 2023 Jan 14;26(2):105987. doi: 10.1016/j.isci.2023.105987. eCollection 2023 Feb 17.

Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis.

Front Pharmacol. 2022 Oct 13;13:958428. doi: 10.3389/fphar.2022.958428. eCollection 2022.

Recent Advances in PROTACs for Drug Targeted Protein Research.

Int J Mol Sci. 2022 Sep 7;23(18):10328. doi: 10.3390/ijms231810328.

本文引用的文献

Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates.

Nat Med. 2017 Apr;23(4):439-449. doi: 10.1038/nm.4290. Epub 2017 Feb 20.

Pleiotropic properties of ASK1.

Biochim Biophys Acta Gen Subj. 2017 Jan;1861(1 Pt A):3030-3038. doi: 10.1016/j.bbagen.2016.09.028. Epub 2016 Sep 30.

DKK3 expression in hepatocytes defines susceptibility to liver steatosis and obesity.

J Hepatol. 2016 Jul;65(1):113-124. doi: 10.1016/j.jhep.2016.03.008. Epub 2016 Mar 23.

Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.

J Hepatol. 2016 Jun;64(6):1365-77. doi: 10.1016/j.jhep.2016.02.002. Epub 2016 Feb 6.

Apoptosis signal-regulating kinase 1 as a therapeutic target.

Expert Opin Ther Targets. 2014 Jun;18(6):651-64. doi: 10.1517/14728222.2014.896903. Epub 2014 Mar 24.

From NAFLD to NASH to cirrhosis-new insights into disease mechanisms.

Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):627-36. doi: 10.1038/nrgastro.2013.149. Epub 2013 Aug 20.

Cellular FLICE-inhibitory protein protects against cardiac remodeling induced by angiotensin II in mice.

Hypertension. 2010 Dec;56(6):1109-17. doi: 10.1161/HYPERTENSIONAHA.110.157412. Epub 2010 Oct 25.

Role of MAPKs in development and differentiation: lessons from knockout mice.

Biochimie. 2006 Sep;88(9):1091-8. doi: 10.1016/j.biochi.2006.06.003. Epub 2006 Jun 27.

Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis.

Gastroenterology. 2003 Aug;125(2):437-43. doi: 10.1016/s0016-5085(03)00907-7.

ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis.

EMBO Rep. 2001 Mar;2(3):222-8. doi: 10.1093/embo-reports/kve046.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

NASH: Novel therapeutic strategies targeting ASK1 in NASH.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献